Understanding how Merkel cell carcinoma develops
Unraveling the regulatory circuits that drive Merkel cell carcinoma
This study is looking into how a virus can cause Merkel cell carcinoma, a type of skin cancer, by changing normal cells into cancerous ones, and it aims to find new ways to understand and treat this condition better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10911200 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind Merkel cell carcinoma (MCC), a type of skin cancer linked to a viral infection. By studying how specific viral oncogenes influence normal cells to become cancerous, researchers aim to uncover the molecular changes that lead to tumor formation and metastasis. The approach involves using advanced techniques to measure gene expression and observe the sequence of events that occur during carcinogenesis, providing insights that traditional methods cannot offer. This could lead to a better understanding of MCC and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Merkel cell carcinoma or those at high risk due to viral infections.
Not a fit: Patients with other types of skin cancer or those not affected by Merkel cell polyomavirus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with Merkel cell carcinoma.
How similar studies have performed: Previous research has shown promise in understanding cancer mechanisms through viral interactions, suggesting potential for success in this novel approach.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Padi, Megha — University of Arizona
- Study coordinator: Padi, Megha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.